| Acute Ischemic Stroke Management | Lifetime | 69 | GR 1 | 99.70 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 88 | GR 1 | 99.66 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 108 | GR 1 | 99.62 |
| Stroke Rehabilitation and Recovery | Lifetime | 82 | GR 1 | 99.49 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 147 | GR 1 | 99.42 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 65 | GR 1 | 99.26 |
| Long-Term Effects of COVID-19 | Lifetime | 183 | GR 2 | 98.21 |
| Cerebral Venous Sinus Thrombosis | Lifetime | 92 | GR 1 | 98.51 |
| Cardiovascular Health and Disease Prevention | Lifetime | 233 | GR 6 | 98.75 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 496 | GR 2 | 98.78 |
| Cardiovascular and Diving-Related Complications | Lifetime | 150 | GR 1 | 97.70 |
| Blood Pressure and Hypertension Studies | Lifetime | 854 | GR 13 | 97.73 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 639 | GR 1 | 97.22 |
| Intracranial Aneurysms: Treatment and Complications | Lifetime | 724 | GR 1 | 97.06 |
| Neurosurgical Procedures and Complications | Lifetime | 645 | GR 2 | 94.79 |
| Cerebrovascular and genetic disorders | Lifetime | 406 | GR 2 | 86.69 |
| Aortic Thrombus and Embolism | Lifetime | 663 | GR 9 | 68.24 |
| Acute Ischemic Stroke Management | 2021-2025 | 7 | GR 1 | 99.87 |
| Stroke Rehabilitation and Recovery | 2021-2025 | 7 | GR 1 | 99.72 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 11 | GR 1 | 99.69 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 47 | GR 1 | 99.23 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 43 | GR 1 | 97.95 |
| Long-Term Effects of COVID-19 | 2021-2025 | 265 | GR 4 | 97.07 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 361 | GR 1 | 95.00 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 208 | GR 1 | 95.43 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 621 | GR 10 | 95.79 |
| Cardiovascular and Diving-Related Complications | 2021-2025 | 75 | GR 2 | 90.38 |
| Neurosurgical Procedures and Complications | 2021-2025 | 251 | GR 1 | 89.36 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 303 | GR 3 | 88.38 |
| Cerebral Venous Sinus Thrombosis | 2021-2025 | 283 | GR 1 | 85.20 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 255 | GR 2 | 79.04 |
| S100 Proteins and Annexins | 2021-2025 | 413 | GR 1 | 73.04 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 725 | GR 4 | 69.96 |
| Myasthenia Gravis and Thymoma | 2021-2025 | 845 | GR 14 | 66.93 |
| Cerebrovascular and genetic disorders | 2021-2025 | 245 | GR 3 | 66.08 |
| Moyamoya disease diagnosis and treatment | 2021-2025 | 777 | GR 5 | 60.81 |
| Glycogen Storage Diseases and Myoclonus | 2021-2025 | 868 | GR 3 | 47.88 |
